The U.S. pharma Sunovion has said its under-the-tongue film for Parkinson's has hit target in a late stage trial by improving motor function compared with placebo, and could be on the market next year ...

Stroke poses a major threat to public health, and this threat is predicted to worsen in the years to come. Simcere is a company dedicated to creating novel therapeutic solutions to meet this urgent ...

In my previous post, I shared my journey discovering that low-dose sublingual (LDSL) ketamine produces remarkable results in patients with treatment-resistant depression. Now, let's explore why lower ...

Bial has introduced a new sublingual formulation of apomorphine in the UK, offering a fresh treatment option for adults with Parkinson’s disease who experience intermittent OFF episodes that are not ...

Please provide your email address to receive an email when new articles are posted on . In pediatric patients, Anaphylm produced a maximum concentration that “slightly exceeded” the one found in ...

Vitamin B12 is an essential nutrient required for maintaining the health of nerve cells and red blood cells. Moreover, it plays a crucial role in DNA formation, which constitutes the genetic material ...

Git isn’t hard to learn. Moreover, with a Git GUI such as Atlassian’s Sourcetree, and a SaaS code repository such as Bitbucket, mastery of the industry’s most powerful version control tools is within ...

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years. (HealthDay News) — The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine ...

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults. The approval is the first for a fibromyalgia ...

A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for epinephrine ...

There were no differences in pain control at 30 minutes among patients who received sublingual sufentanil vs standard care for blunt trauma. Sublingual sufentanil does not reduce pain more effectively ...